Effects of a flaxseed-derived lignan supplement in type 2 diabetic patients: A randomized, double-blind, cross-over trial

Agriculture & Biology

• animals 2%
• bioavailability 6%
• blood lipids 14%
• China 8%
• cross-over studies 75%
• excretion 10%
• fasting 13%
• glucose 8%
• glycemic control 41%
• glycohemoglobin 20%
• hypercholesterolemia 8%
• insulin 5%
• insulin resistance 32%
• isoflavones 7%
• lignans 77%
• linseed 78%
• lipids 10%
• metabolites 4%
• methodology 1%
• noninsulin-dependent diabetes mellitus 8%
• placebos 21%

Medicine & Life Sciences

• 2,3-bis(3'-hydroxybenzyl)butane-1,4-diol 11%
• 2,3-bis(3'-hydroxybenzyl)butyrolactone 11%
• Animals 3%
• Biological Availability 6%
• Capsules 6%
• China 5%
• Cross-Over Studies 61%
• Fasting 10%
• Flax 100%
• Glucose 8%
• Hypercholesterolemia 6%
• Insulin 4%
• Insulin Resistance 21%
• Isoflavones 8%
• Lignans 92%
• Lipids 21%
• Placebos 13%
• Type 2 Diabetes Mellitus 5%

Chemical Compounds

• Bioavailability 6%
• Enterodiol 12%
• Enterolactone 11%
• Glucose 9%
• Glycemic 41%
• Insulin Derivative 34%
• Isoflavones 9%
• Lignan 81%
• Lipid 23%
• Metabolite 4%
• Resistance 8%